| Jessica Greinke, MD | |
|
8960 Commerce Dr Ste 4e, De Soto, KS 66018-8431 | |
| (913) 789-3961 | |
| (913) 583-3667 |
| Full Name | Jessica Greinke |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 12 Years |
| Location | 8960 Commerce Dr Ste 4e, De Soto, Kansas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1447517495 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 04-38485 (Kansas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Adventhealth Shawnee Mission | Shawnee mission, KS | Hospital |
| Kansas City Orthopaedic Institute | Leawood, KS | Hospital |
| Saint Luke's South Hospital | Overland park, KS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Shawnee Mission Medical Center Inc | 9537119037 | 177 |
News Archive
Officials from special needs plan providers said Thursday at a Capitol Hill briefing that they will provide Congress with more data on the services the plans provide to beneficiaries with severe chronic medical conditions, CQ HealthBeat reports.
Pfizer Inc announced that the Phase 3 INTORSECT (B1771003) study, evaluating TORISEL(temsirolimus) in patients with advanced renal cell carcinoma (RCC) whose disease had progressed on or after SUTENT (sunitinib malate) therapy, did not meet the primary endpoint of prolonging progression free survival (PFS) when compared to sorafenib.
Disguising a molecule to get it past the body's immune system could greatly enhance the success of a groundbreaking new therapy, Cancer Research UK scientists report in the British Journal of Cancer this week.
On behalf of the United States, HHS Secretary Tommy G. Thompson signed the Framework Convention on Tobacco Control (FCTC) on Monday at the United Nations. The FCTC is the first-ever global public health treaty negotiated under the auspices of the World Health Organization (WHO).
Just weeks after HHS released the first national strategy to reduce racial and ethnic health disparities, a new study published in the journal Demography suggests there is a flaw in the method used to measure racial health differences: it does not adequately account for people of mixed race.
› Verified 2 days ago
| Entity Name | Shawnee Mission Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992735690 PECOS PAC ID: 9537119037 Enrollment ID: O20050701000310 |
News Archive
Officials from special needs plan providers said Thursday at a Capitol Hill briefing that they will provide Congress with more data on the services the plans provide to beneficiaries with severe chronic medical conditions, CQ HealthBeat reports.
Pfizer Inc announced that the Phase 3 INTORSECT (B1771003) study, evaluating TORISEL(temsirolimus) in patients with advanced renal cell carcinoma (RCC) whose disease had progressed on or after SUTENT (sunitinib malate) therapy, did not meet the primary endpoint of prolonging progression free survival (PFS) when compared to sorafenib.
Disguising a molecule to get it past the body's immune system could greatly enhance the success of a groundbreaking new therapy, Cancer Research UK scientists report in the British Journal of Cancer this week.
On behalf of the United States, HHS Secretary Tommy G. Thompson signed the Framework Convention on Tobacco Control (FCTC) on Monday at the United Nations. The FCTC is the first-ever global public health treaty negotiated under the auspices of the World Health Organization (WHO).
Just weeks after HHS released the first national strategy to reduce racial and ethnic health disparities, a new study published in the journal Demography suggests there is a flaw in the method used to measure racial health differences: it does not adequately account for people of mixed race.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jessica Greinke, MD 8960 Commerce Dr Ste 4e, De Soto, KS 66018-8431 Ph: (913) 789-3961 | Jessica Greinke, MD 8960 Commerce Dr Ste 4e, De Soto, KS 66018-8431 Ph: (913) 789-3961 |
News Archive
Officials from special needs plan providers said Thursday at a Capitol Hill briefing that they will provide Congress with more data on the services the plans provide to beneficiaries with severe chronic medical conditions, CQ HealthBeat reports.
Pfizer Inc announced that the Phase 3 INTORSECT (B1771003) study, evaluating TORISEL(temsirolimus) in patients with advanced renal cell carcinoma (RCC) whose disease had progressed on or after SUTENT (sunitinib malate) therapy, did not meet the primary endpoint of prolonging progression free survival (PFS) when compared to sorafenib.
Disguising a molecule to get it past the body's immune system could greatly enhance the success of a groundbreaking new therapy, Cancer Research UK scientists report in the British Journal of Cancer this week.
On behalf of the United States, HHS Secretary Tommy G. Thompson signed the Framework Convention on Tobacco Control (FCTC) on Monday at the United Nations. The FCTC is the first-ever global public health treaty negotiated under the auspices of the World Health Organization (WHO).
Just weeks after HHS released the first national strategy to reduce racial and ethnic health disparities, a new study published in the journal Demography suggests there is a flaw in the method used to measure racial health differences: it does not adequately account for people of mixed race.
› Verified 2 days ago